"Hodgkin Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
Descriptor ID |
D006689
|
MeSH Number(s) |
C04.557.386.355 C15.604.515.569.355 C20.683.515.761.355
|
Concept/Terms |
Hodgkin Disease- Hodgkin Disease
- Disease, Hodgkin
- Granuloma, Hodgkin's
- Hodgkin's Granuloma
- Granuloma, Hodgkins
- Hodgkins Granuloma
- Lymphogranuloma, Malignant
- Lymphogranulomas, Malignant
- Malignant Lymphogranuloma
- Malignant Lymphogranulomas
- Hodgkin Lymphoma
- Lymphoma, Hodgkin
- Hodgkin's Disease
- Disease, Hodgkin's
- Hodgkin's Lymphoma
- Hodgkins Lymphoma
- Lymphoma, Hodgkin's
- Hodgkins Disease
- Disease, Hodgkins
- Granuloma, Hodgkin
- Hodgkin Granuloma
- Granuloma, Malignant
- Malignant Granuloma
- Malignant Granulomas
|
Below are MeSH descriptors whose meaning is more general than "Hodgkin Disease".
Below are MeSH descriptors whose meaning is more specific than "Hodgkin Disease".
This graph shows the total number of publications written about "Hodgkin Disease" by people in this website by year, and whether "Hodgkin Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
2003 | 2 | 0 | 2 |
2004 | 3 | 0 | 3 |
2005 | 1 | 0 | 1 |
2006 | 4 | 0 | 4 |
2007 | 2 | 0 | 2 |
2008 | 4 | 0 | 4 |
2010 | 1 | 0 | 1 |
2011 | 2 | 0 | 2 |
2012 | 3 | 1 | 4 |
2013 | 1 | 1 | 2 |
2014 | 1 | 0 | 1 |
2017 | 3 | 0 | 3 |
2018 | 1 | 0 | 1 |
2019 | 2 | 0 | 2 |
2020 | 4 | 1 | 5 |
2021 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hodgkin Disease" by people in Profiles.
-
Arter ZL, Meghpara S, Mignano S, Berenberg J. A Rare Coexistence of Seminoma and Hodgkin's Lymphoma in Hawai'i. Hawaii J Health Soc Welf. 2021 12; 80(12):295-297.
-
Davidow K, Bunin N, Goldfarb S, Li Y, Freedman JL. Pulmonary Outcomes After Autologous Stem Cell Transplant for Hodgkin Lymphoma. J Pediatr Hematol Oncol. 2022 08 01; 44(6):e926-e929.
-
Harer K, Mann J, Muhlbauer N, Welch J, Alverson B. A Case Report of Pediatric Paraneoplastic Dysautonomia. Pediatr Emerg Care. 2020 Dec; 36(12):e742-e744.
-
Nagpal P, Descalzi-Montoya DB, Lodhi N. The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV, and exosomes. Cancer Rep (Hoboken). 2021 04; 4(2):e1311.
-
Mostyka M, Birch MM, Samstein B, Pittman ME. Hidden Carcinoma: Pitfalls in the Diagnosis of Lymphoepithelioma-Like Cholangiocarcinoma. Int J Surg Pathol. 2020 Dec; 28(8):872-878.
-
Damlaj M, Abuelgasim KA, Alhejazi A, Alahmari B, Alaskar A, Alzahrani M. Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma. Bone Marrow Transplant. 2020 12; 55(12):2322-2325.
-
Gittens AT, Clarke JD, Abdelbaki S, Kwon JS. A 72-Year-Old Man With a Violaceous Rash?and Sepsis. Chest. 2020 02; 157(2):e41-e45.
-
Cohen JB, Wei L, Maddocks KJ, Christian B, Heffner LT, Langston AA, Lechowicz MJ, Porcu P, Flowers CR, Devine SM, Blum KA. Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study. Cancer. 2020 03 15; 126(6):1235-1242.
-
Abuelgasim KA, Alzahrani M, Alsharhan Y, Khairi M, Hommady M, Gmati G, Salama H, Ali O, Alahmari B, Masuadi EM, Alaskar A, Alhejazi A, Damlaj M. Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma. Bone Marrow Transplant. 2019 07; 54(7):1168-1172.
-
Jain S, Gupta A, Nagalla S. A Mediastinal Mass in a Young Man. JAMA. 2018 06 19; 319(23):2432-2433.